Lisa joined Almac Discovery in 2016 and has responsibility for the project management of preclinical and clinical programs. She has 10 years of mainly oncology experience gained across both drug development and stratified medicine.Click to Read More
Prior to Almac Discovery as Senior Project Manager at Qiagen, Lisa witnessed the FDA approvals and launch of therascreen® KRAS and EGFR colorectal and metastatic non-small cell lung cancer diagnostic kits and managed extensive programs for gene expression-based diagnostic kits. This is valuable for Discovery’s Precision Therapeutics approach to drug development.
Prior to Qiagen Lisa worked for Almac Diagnostic Services Project Management and held post-doctoral positions at Astra Zeneca.
Lisa has a Ph.D in Molecular Biology from the University of Manchester.